Cargando…

Blood-brain barrier impairment in MPS III patients

BACKGROUND: Mucopolysaccharidosis type III (MPS III) is an autosomal recessive disorder caused by deficiency of a specific enzyme leading to heparan sulfate (HS) accumulation within cells and to eventual progressive cerebral and systemic organ abnormalities. Different enzyme deficiencies comprise th...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbuzova-Davis, Svitlana, Mirtyl, Santhia, Sallot, Sebastian A, Hernandez-Ontiveros, Diana G, Haller, Edward, Sanberg, Paul R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835134/
https://www.ncbi.nlm.nih.gov/pubmed/24225396
http://dx.doi.org/10.1186/1471-2377-13-174
_version_ 1782292107261640704
author Garbuzova-Davis, Svitlana
Mirtyl, Santhia
Sallot, Sebastian A
Hernandez-Ontiveros, Diana G
Haller, Edward
Sanberg, Paul R
author_facet Garbuzova-Davis, Svitlana
Mirtyl, Santhia
Sallot, Sebastian A
Hernandez-Ontiveros, Diana G
Haller, Edward
Sanberg, Paul R
author_sort Garbuzova-Davis, Svitlana
collection PubMed
description BACKGROUND: Mucopolysaccharidosis type III (MPS III) is an autosomal recessive disorder caused by deficiency of a specific enzyme leading to heparan sulfate (HS) accumulation within cells and to eventual progressive cerebral and systemic organ abnormalities. Different enzyme deficiencies comprise the MPS III subcategories (A, B, C, D). Since neuropathological manifestations are common to all MPS III types, determining blood-brain barrier (BBB) condition may be critical to understand potential additional disease mechanisms. METHODS: We investigated BBB integrity in various brain structures of post-mortem tissues from an eleven year old Caucasian female with MPS III A and from a twenty four year old Caucasian female with MPS III D. Control tissues were obtained post-mortem from three Caucasians without neurological deficits: a twelve year old male, a twenty four year old female, and a twenty seven year old female. BBB capillary ultrastructure (electron microscopy) and capillary functional integrity (IgG leakage, tight junction proteins, and lysosomal accumulation within endothelium) were examined. RESULTS: Compromised BBB integrity was found in both MPS III cases. Major study findings were: (1) capillary endothelial and pericyte cell damage; (2) mucopolysaccharide bodies in a majority of endothelial cells and pericytes rupturing cell membranes; (3) severe extracellular edema; (4) IgG microvascular leakage and reductions of occludin and claudin-5 with variations between MPS III types; (5) extensive lysosomal accumulation in capillary endothelium. CONCLUSIONS: These new findings of BBB structural and functional impairment, although from only two cases, MPS III A and III D, may have implications for disease pathogenesis and should be considered in treatment development for MPS III.
format Online
Article
Text
id pubmed-3835134
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38351342013-11-21 Blood-brain barrier impairment in MPS III patients Garbuzova-Davis, Svitlana Mirtyl, Santhia Sallot, Sebastian A Hernandez-Ontiveros, Diana G Haller, Edward Sanberg, Paul R BMC Neurol Research Article BACKGROUND: Mucopolysaccharidosis type III (MPS III) is an autosomal recessive disorder caused by deficiency of a specific enzyme leading to heparan sulfate (HS) accumulation within cells and to eventual progressive cerebral and systemic organ abnormalities. Different enzyme deficiencies comprise the MPS III subcategories (A, B, C, D). Since neuropathological manifestations are common to all MPS III types, determining blood-brain barrier (BBB) condition may be critical to understand potential additional disease mechanisms. METHODS: We investigated BBB integrity in various brain structures of post-mortem tissues from an eleven year old Caucasian female with MPS III A and from a twenty four year old Caucasian female with MPS III D. Control tissues were obtained post-mortem from three Caucasians without neurological deficits: a twelve year old male, a twenty four year old female, and a twenty seven year old female. BBB capillary ultrastructure (electron microscopy) and capillary functional integrity (IgG leakage, tight junction proteins, and lysosomal accumulation within endothelium) were examined. RESULTS: Compromised BBB integrity was found in both MPS III cases. Major study findings were: (1) capillary endothelial and pericyte cell damage; (2) mucopolysaccharide bodies in a majority of endothelial cells and pericytes rupturing cell membranes; (3) severe extracellular edema; (4) IgG microvascular leakage and reductions of occludin and claudin-5 with variations between MPS III types; (5) extensive lysosomal accumulation in capillary endothelium. CONCLUSIONS: These new findings of BBB structural and functional impairment, although from only two cases, MPS III A and III D, may have implications for disease pathogenesis and should be considered in treatment development for MPS III. BioMed Central 2013-11-13 /pmc/articles/PMC3835134/ /pubmed/24225396 http://dx.doi.org/10.1186/1471-2377-13-174 Text en Copyright © 2013 Garbuzova-Davis et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Garbuzova-Davis, Svitlana
Mirtyl, Santhia
Sallot, Sebastian A
Hernandez-Ontiveros, Diana G
Haller, Edward
Sanberg, Paul R
Blood-brain barrier impairment in MPS III patients
title Blood-brain barrier impairment in MPS III patients
title_full Blood-brain barrier impairment in MPS III patients
title_fullStr Blood-brain barrier impairment in MPS III patients
title_full_unstemmed Blood-brain barrier impairment in MPS III patients
title_short Blood-brain barrier impairment in MPS III patients
title_sort blood-brain barrier impairment in mps iii patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835134/
https://www.ncbi.nlm.nih.gov/pubmed/24225396
http://dx.doi.org/10.1186/1471-2377-13-174
work_keys_str_mv AT garbuzovadavissvitlana bloodbrainbarrierimpairmentinmpsiiipatients
AT mirtylsanthia bloodbrainbarrierimpairmentinmpsiiipatients
AT sallotsebastiana bloodbrainbarrierimpairmentinmpsiiipatients
AT hernandezontiverosdianag bloodbrainbarrierimpairmentinmpsiiipatients
AT halleredward bloodbrainbarrierimpairmentinmpsiiipatients
AT sanbergpaulr bloodbrainbarrierimpairmentinmpsiiipatients